miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling.
miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling. — المؤلف: Xiao, Shuai — Oncogenesis Nov 2018
- المؤلف
- Xiao, Shuai
- النشر
- Oncogenesis Nov 2018
- الوصف
- 90 p.